- Elite Trade Club
- Posts
- Oncology Biotech Firm Jumps on Nasdaq Compliance, Earns 93% Gains
Oncology Biotech Firm Jumps on Nasdaq Compliance, Earns 93% Gains
Adam Garcia
June 05, 2025
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
A New Chapter in Home Construction
And it has 40,000+ investors excited about BOXABL. Their houses fold up and deliver, then set up in hours. How? They brought assembly-line manufacturing to housing, rolling new homes off the line in ~4 hours. Now, BOXABL’s preparing for Phase 2, combining modules into larger homes and apartments – and until 6/24, you can join.
*This is a paid advertisement for Boxabl’s Regulation A offering. Please read the offering circular at https://invest.boxabl.com/#circular
Markets
Wall Street turned bearish on Thursday amid a decline in Tesla stock following fallout between President Donald Trump and Elon Musk.
|
|
Market-Moving News
Consumer
$1.6B Shakeup: P&G to Cut 7,000 Jobs and Exit Brands as Trade Pressures Rise
Procter & Gamble (NYSE: PG) will eliminate 7,000 jobs over the next two years and step away from several brands and markets as part of a major restructuring effort. The company framed these moves as an acceleration of its existing strategy to navigate a tougher global environment.
The job cuts account for approximately 6% of its global workforce, primarily outside of the manufacturing sector. At the same time, P&G plans to exit entire product categories and could pursue divestitures. With tariffs from China driving up costs and softening consumer confidence in key markets, the company estimates a $600 million before-tax hit in fiscal 2026.
For those evaluating corporate performance, the company’s shift signals a bigger trend: even large, established players must adapt quickly to cost volatility and political risk. Procter & Gamble is choosing to protect margins through a mix of layoffs, simplified structure, and pricing power.
While such a reset may create short-term disruptions, long-term gains could result from a sharper brand focus and fewer low-performing segments.
What’s important to understand is that this is not a growth play, but it’s a durability strategy. P&G is prioritizing stability and cost control over scale, betting that a tighter ship will weather rougher waters better than a bloated one.
P&G expects to take charges of up to $1.6 billion through 2027, with some non-cash components. Despite 90% of its U.S. sales coming from domestic production, the ripple effects of tariffs and global instability are forcing the Pampers maker to adapt quickly.
Altcoin Predictions (Sponsored)
Bitcoin is booming. ETFs are breaking records.
But the world’s top crypto minds say this is only the beginning.
An exclusive summit just opened access to 27 crypto insiders—including Tether’s co-creator and top fund managers—to share altcoin plays, ETF windfall predictions, and real-time market moves.
This exclusive summit offers rare insight into where the smart money is headed next.
Packaged Goods
Kimberly-Clark Restructures with $1.73B Cash Boost from Suzano
Kimberly-Clark (NYSE: KMB) is offloading control of its international tissue business in a $3.4 billion deal with Brazilian pulp giant Suzano, reshaping its global strategy to focus on higher-margin segments.
Under the agreement, Kimberly-Clark will hold a 49% stake in the new joint venture, while Suzano will have 51% and pay $1.73 billion in cash. The deal will include 22 manufacturing sites across 14 countries, primarily in Europe, Asia, the Middle East, and Central America.
Kimberly-Clark will contribute 9,000 employees and the assets of its international family care and professional operations to the new company, which will be based in the Netherlands.
For those watching Kimberly-Clark, this is a significant shift. The company has been working to reduce its exposure to rising input costs and streamline its operations. By handing over control of the volatile tissue segment outside North America, it now has more room to focus on personal care products and core markets, such as the U.S. and Canada.
The move gives Kimberly-Clark flexibility in a challenging macroeconomic environment and mitigates risk from overseas cost fluctuations. Analysts suggest this deal could ease investor concerns by injecting fresh capital and lowering pressure on margins.
Kimberly-Clark will retain its tissue and professional businesses in North America, as well as its stakes in joint ventures in Mexico, South Korea, and Bahrain. The company said Suzano may also purchase the remaining stake under specific terms.
The transaction is expected to close by mid-2026.
ETF Surge (Sponsored)
Trump’s recent crypto announcement just triggered a major market shift—right as Bitcoin and ETFs hit fresh highs.
Institutional money is pouring in, but some of the smartest minds in crypto are looking beyond Bitcoin.
Now, 27 top insiders—co-creators of Tether, Solana, and THORChain—are revealing what comes next.
From hidden altcoin plays to major predictions, this is rare access to crypto’s elite.
Digital Assets
Circle Breaks Through with $1.1B IPO, Joins Elite Club of U.S.-Listed Crypto Firms
Circle (NYSE: CRCL) made its public debut on Thursday with an IPO that raised nearly $1.1 billion, launching the stablecoin company into a small but growing group of U.S.-listed crypto-native firms.
The New York-based company priced its IPO at $31 per share, which is well above its expected range of $27 to $28. That initial pricing gave Circle a pre-trading valuation of $6.8 billion.
Circle's listing follows a prior failed attempt to go public via SPAC in 2022. This time, the company entered the market amid a more favorable political backdrop for crypto, particularly stablecoins. Analysts expect the sector to expand rapidly, with some projecting a tenfold increase in stablecoin adoption over the next five years.
For crypto-aligned equity traders, Circle now offers direct exposure to a company that plays a key role in the U.S. digital finance infrastructure. It also becomes one of only a few regulated crypto firms alongside Coinbase and Riot Platforms listed on U.S. exchanges.
The company and its selling shareholders secured a substantial capital influx, which could provide flexibility for future investments, partnerships, or regulatory navigation as stablecoin frameworks evolve.
Circle's IPO success signals renewed institutional appetite for crypto firms with a focus on compliance and transparency.
Top Winners and Losers
Liminatus Pharma Inc [LIMN] $24.60 (+93.55%)
Liminatus Pharma, an immuno-oncology company, surged after announcing it regained Nasdaq compliance through a timely 10-Q filing, easing immediate delisting concerns despite ongoing financial uncertainty.
Planet Labs Pbc [PL] $5.97 (+49.19%)
Planet Labs rallied after a strong Q1 earnings beat and raised guidance, supported by record free cash flow, robust government demand, and a surging $527 million backlog.
Iperionx Limited [IPX] $29.12 (+19.25%)
IperionX climbed after securing a $99 million contract with the U.S. Department of Defense, demonstrating its titanium tech is ready for large-scale military deployment.
Ctrl Group Limited [MCTR] $7.40 (-51.95%)
CTRL Group plunged more than 50% for the second session after a trading halt and sharp reversal from its retail-fueled rally earlier this week, erasing previous gains and tumbling 86% from its recent peak.
Mullen Automotive Inc [MULN] $8.20 (-49.07%)
Mullen Automotive dropped sharply after enacting its seventh reverse stock split since 2023, deepening investor skepticism over its viability and cash position.
Regenxbio Inc [RGNX] $8.36 (-17.06%)
Regenxbio shares slid despite promising trial results, as investors saw limited threat to rival Sarepta’s market dominance in Duchenne muscular dystrophy.
Q2 Market Movers (Sponsored)
Summer market momentum is here—and these 7 tickers are at the center of it.
This free investor guide features top-ranked stocks selected for their growth potential, market trends, and expert analysis.
It’s a must-read for anyone looking to position their portfolio for a strong second half.
The list is available for FREE, but only for a limited time.
Everything Else
Disney says its U.S. theme parks generate $67B a year in economic impact.
Weekly jobless claims hit the highest level in seven months, while imports saw the steepest drop on record.
Silver prices climb to 13-year high, lifted by weak dollar and tariff concerns.
Tesla stock slides after Trump says he’s ‘disappointed’ in Musk’s harsh tax bill criticism.
Anduril has secured a $30.5 billion valuation in its latest fundraising round, underscoring investor confidence.
Delta warns that new tariffs may force the airline to halt purchases of foreign-made aircraft, raising concerns across the aviation industry.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
